INJ Price Analysis: $9 Breakout in Focus as Injective ETF Hopes Grow

Injective (INJ) is consolidating near $8 after recovering from August lows, with buyers trying to sustain the uptrend. Three U.S. ETF applications have strengthened the institutional-access narrative, while a proposed gas-fee upgrade targets transaction predictability. A breakout above $9 could open further upside, with ETF hopes and network developments drawing renewed attention to the token.